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Abstract: We report an educational autopsy case of combined pulmonary fibrosis and 
emphysema. Radiological patterns of the upper lung were considered as mostly emphysema, 
but pathological observation revealed significant interstitial fibrosis of usual interstitial pneumo-
nia as a major pathology. The patient eventually developed acute exacerbation of background 
interstitial pneumonia. Careful radiological and pathological correlation of the current case 
indicates that regions with distal acinar emphysema on computed tomography image may pos-
sess histologically marked dense fibrosis of lethal interstitial pneumonia.
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Introduction
Historically, pulmonary emphysema is a classic condition of obstructive disease while 
pulmonary fibrosis is a prototype of restrictive disease. These two conditions had been 
considered as diseases of different spectrums. However, coexistence of pulmonary 
emphysema and fibrosis has been reported increasingly during recent years, in which 
Cottin et al proposed a new concept of combined pulmonary fibrosis and emphysema 
(CPFE) as a distinctive condition of diffuse lung disease.1 Cases with such combined 
condition have been widely recognized,2,3 however, in the current American Thoracic 
Society/European Respiratory Society (ATS/ERS) statement of idiopathic interstitial 
pneumonias, CPFE is described as an example of coexisting patterns comprising a 
heterogeneous population of patients and a syndrome which does not achieve a con-
sensual understanding in the societies.4
An increasing number of publications describe combination of emphysema and 
interstitial fibrosis as having frequent association with carcinomas and pulmonary 
hypertension.5–8 Accurate recognition of background interstitial fibrosis may have high 
clinical importance considering the risk of lethal acute exacerbation. The biological 
relationship between emphysema and interstitial fibrosis is still uncertain and whether 
they are two different diseases simply associated with cigarette smoking or diseases of 
one spectrum. In that sense, studies of careful radiological and pathological correlation 
of combined emphysema and fibrosis cases are needed.
Clinical history
An 83-year old male with smoking history of 63 pack years was diagnosed with 
interstitial lung disease by chest radiograph at 76 years of age. Before presentation he 
had also recently been diagnosed with rheumatoid arthritis based on 2010 Rheuma-
toid Arthritis Classification and had been on low dose of prednisolone (5 mg/day).9 
Correspondence: Junya Fukuoka
Department of Pathology, Nagasaki 
University Graduate school of  
Biomedical sciences, 1-7-1, sakamoto,  
Nagasaki 852-8501, Japan
tel +81 95 819 7055
Fax +81 95 819 7056
email fukuokaj@nagasaki-u.ac.jp 
Journal name: International Journal of COPD
Article Designation: Case report
Year: 2015
Volume: 10
Running head verso: Karata et al
Running head recto: Combined pulmonary fibrosis and emphysema
DOI: http://dx.doi.org/10.2147/COPD.S83521





He then presented with respiratory symptoms after 2 weeks 
and pulmonary medicine specialists were consulted. He was 
treated with antibiotics under clinical diagnosis of infec-
tious pneumonia, but did not respond well to treatment and 
further presented with right chest pain and fatigue a week 
later. At that time, he also developed renal dysfunction. Due 
to the serum elevation of myeloperoxidase anti-neutrophil 
cytoplasmic antibody (MPO-ANCA), the patient was sus-
pected to have ANCA-related glomerular nephritis and was 
administered high dose methylprednisolone (500 mg/day). 
Computed tomography (CT) images were taken at the time 
of admission revealing a right lower lobe mass, which was 
biopsied and confirmed to be pulmonary adenocarcinoma. 
Due to the advanced stage of the carcinoma and patient’s 
poor performance status, best supportive care was selected. 
Two weeks after admission, pulmonary dysfunction rapidly 
progressed to respiratory failure, resulting in his passing 




 level at that time 
was 60 mmHg. Pulmonary function test was not performed 
due to the poor physical status of the patient. Serological test 
at the time of admission indicated the following abnormali-
ties: CRP 16.56 mg/dL; KL-6- 520.8 U/mL; MPO-ANCA- 
257 IU/mL; antinuclear antibody ×160.
Radiological findings
CT images taken at the time of admission showed paraseptal 
and centriacinar emphysema with mild reticulation pre-
dominantly in both upper lobes (Figure 1A). Fine and coarse 
reticulation with mild bronchiectasis and honeycomb-like 
cystic airspaces were also seen with basal and peripheral pre-
dominance (Figure 1B, C), which were originally considered to 
be a combination of upper-zone simple emphysema and lower-
zone pulmonary fibrosis. At the top of the right lower lobe, a 
lobulated solid mass of adenocarcinoma was seen (Figure 1B). 
The marginal zone of emphysematous areas was relatively clear 
and irregular compared to “simple” emphysema (Figure 1A). 
Some areas of emphysema were admixed with reticulation, 
and fine reticulations and limited ground glass opacification 
were seen adjacent to the low attenuation areas.
Pathological findings
By gross pathology, subpleural cystic changes were obvious 
throughout craniocaudal levels, most prominent in the lower 
lungs. Remaining lung areas were yellow to brown in color 
with solid appearance (Figure 2).
Histologically, lower lungs indicated numerous cystic 
spaces corresponding to honeycomb cysts bilaterally, in which 
several cystic spaces were surrounded by dense fibrosis and 
filled with mucus. Most of these cysts were covered by the 
columnar bronchiolar type epithelia. Right lower lobe showed 
emphysematous lesions radiologically and macroscopically, 
but microscopic observation revealed marked interstitial 
fibrosis and smooth muscle hyperplasia (Figure 3). Patchy, 
peripheral-dominant dense fibrosis was observed. Fibroblastic 
foci were inconspicuous but found in the wall of honeycomb 
cysts. Right upper lobe appearing to be non-fibrotic tissue 
radiologically also demonstrates focal interstitial fibrosis and 
smooth muscle hyperplasia (Figure 4). Furthermore, left upper 
lobe indicates paraseptal emphysema with minimal reticula-
tion in the radiological observation. However, it turned out to 
have remarkable fibrotic changes histologically corresponding 
to usual interstitial pneumonia (Figure 5).
Discussion
Histopathological analysis of the autopsied CPFE case 
revealed a surprising discordance between the impression of 
Figure 1 HrCt images of the case.
Notes: (A) HRCT image from right upper lobe: there are mainly paraseptal emphysematous changes in both upper lobes. Note the fine reticulations and limited ground glass 
opacification which are adjacent to the low attenuation areas (arrows). Some areas of emphysema are admixed with reticulation (arrowheads). (B, C) HrCt images from 
right middle to lower zone: there is both paraseptal and centrilobular emphysema. In the middle lobe, emphysema admixed with reticulation (C, arrows) is seen as well as 
in the upper zone (A). Compared to paraseptal emphysema without reticulation in the upper lobe, they show signs of interstitial abnormality (B, arrows). at the top of the 
right lobe, a lobulated solid mass is known lung cancer (B, asterisk). In the right lower lobe, there is fine and coarse reticulation with some cystic changes. The irregularly 
dilated airway, traction bronchiectasis (C, arrowhead), makes it possible to recognize the presence of pulmonary fibrosis (C).
Abbreviation: HrCt, high-resolution computed tomography.




Combined pulmonary fibrosis and emphysema
Figure 2 Gross appearance of the right lung.
Notes: right lung was horizontally cut into eight slices. top row is from upper lung areas showing emphysematous cystic spaces along with brown, normal-appearing area, 
while lower lung areas showed honeycomb changes. arrowheads indicate pulmonary adenocarcinoma showing well circumscribed white, solid mass without remarkable 
necrosis.
Figure 3 Computed tomography images and their corresponding histological images of right lower lobe.
Notes: (A) Computed tomography image shows coarse reticulation with honeycomb-like clustered cystic airspaces. squared area corresponds to microscopic observation (C). 
(B) a gross picture of the same lesion. squared area corresponds to microscopic observation (C). (C) Microscopic observation revealed cystic spaces and interstitial fibrosis. 
arrowheads indicate areas corresponding to honeycomb cysts.
Figure 4 Computed tomography images and their corresponding histological images of right upper lobe.
Notes: (A) Computed tomography image shows subtle fine reticulation (arrow) which can be identified with careful observations. (B) a gross picture of the same area. 
(C) Microscopic observation of squared area in (A, B). (D) Close-up of the squared area in (C) revealed significant interstitial fibrosis.





Figure 5 Computed tomography images and their corresponding histological images of left upper lobe.
Notes: (A) Computed tomography image shows mainly paraseptal and centriacinar emphysema. Note that the marginal zone of the emphysema tous area is clear and irregular 
than usual emphysema (arrow). (B) Gross appearance of the same area shows corresponding emphysematous-looking cystic spaces. (C) Histologically, significant fibrotic 
changes of usual interstitial pneumonia can be identified in the same area. (D) Higher magnification of image C. Formation of honeycomb cysts are found in the upper lobe. (E) 
Honeycomb cysts are covered by mixture of bronchiolar epithelia (arrow), type II pneumocytes (arrowhead), and squamous metaplasia (asterisk). (F) Focal fibroblastic foci 
are found adjacent to dense fibrosis.
CT images and pathological findings. CT images of lower lung 
areas showed reticular shadow corresponding to pulmonary 
fibrosis. However, CT images of upper lung areas were origi-
nally considered to be simple emphysema. On the other hand, 
histological evaluation at autopsy revealed unexpected dense 
fibrosis of usual interstitial pneumonia (UIP) pattern both in 
the upper and lower lung areas.
This discrepancy is clinically important and should not 
be overlooked; in other words, pulmonologists and radiolo-
gists need to be informed of this as a warning. To our best 
knowledge, no case reports have been done on an acute exac-
erbation of diffuse alveolar damage due to emphysema alone. 
On the other hand, it is well known that a significant number 
of cases with pulmonary fibrosis, mainly UIP, accompanies 
acute respiratory failure leading to death.
As is described as characteristic histological patterns 
corresponding to the interstitial fibrosis seen in the smokers’ 
lung, airspace enlargement with fibrosis (AEF) and smoking 
related interstitial fibrosis were reported.10,11 Although AEF and 
smoking related interstitial fibrosis are classified as subclinical 
conditions and clinically unimportant complications in the 
latest guidelines,4 two thirds of AEF cases are associated with 
UIP fibrosis, as Kawabata et al., report in their manuscript.11 
Alternatively, majority of cases indicate the combination of 
AEF and UIP. Another critical problem of this context is that 
there is no consensus of how to diagnose and treat the patients 
with subtle interstitial fibrosis among “mostly emphysema” 
cases. Distinction between emphysema and interstitial fibrosis 
is difficult, and the clinical border of the two conditions seen 
within the same case is vague. Emphysema and pulmonary 
fibrosis were considered to be two different diseases, but the 
possibility that they are on common spectrum still remains. 
Recently, Stanley et al found mutations in TERT gene in 
emphysema patients.12 TERT gene mutation is also known as a 
mutation responsible for familial pulmonary fibrosis, and their 
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Combined pulmonary fibrosis and emphysema
report may explain why these two conditions are difficult to 
separate in certain cases.
Connective tissue disease, especially rheumatoid arthri-
tis, is well known to be associated with pulmonary fibrosis. 
However, connective tissue disease-associated pulmonary 
fibrosis and idiopathic pulmonary fibrosis are often difficult 
to distinguish from one another.13 Similar situation applies to 
MPO-ANCA-related pulmonary fibrosis.14 However, there is 
a limited number of manuscripts describing the relationships 
between CPFE and autoimmune diseases including ANCA, 
thereby making the clear recognition of biological effect 
difficult,15–17 calling for further research in this field.
Cases with CPFE are known to have significantly higher 
risks of carcinoma association.8 This is an important factor to 
mention to pulmonologists, in order to urge careful observation 
of follow-up radiographs when patients present without any 
known carcinomas. As for cases that are already diagnosed 
with lung cancer, general surgical pathologists may focus 
only on staging and differentiating the histological types of 
cancer but not on observing background lung pathologies. 
Considering the risk of lethal acute exacerbation of pulmonary 
fibrosis, careful evaluation of radiographs to judge presence 
of background interstitial fibrosis is important. Some fibrosis 
mixed with emphysema may be subclinical and unimportant. 
However, pulmonary fibrosis generally possesses risks of acute 
exacerbation. Therefore, detection of fibrosis in the wall of 
emphysematous cysts as seen in the present case is critical.
Conclusion
We have examined an autopsy case showing emphysema and 
pulmonary fibrosis, in which the patient developed diffuse 
alveolar damage as an acute exacerbation. Radiological and 
pathological correlation of the current case indicates that 
simple emphysema on CT may possess characteristics of 
usual interstitial pneumonia histologically, which can later 
lead to lethal acute exacerbation.
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